News Summary

• (Reuters)The litigation has resulted in more than $50 billion in settlements with drugmakers, distributors and pharmacy chains.Plaintiffs accused McKinsey of contributing to the deadly drug crisis by helping drug manufacturers, including Purdue Pharma – the maker of OxyContin – create deceptive marketing strategies to increase sales of painkillers..
• The firm previously paid $641.5 million to resolve claims by state attorneys general and another $230 million to resolve claims by local governments..